| Product NDC: | 17478-107 |
| Proprietary Name: | Levofloxacin |
| Non Proprietary Name: | Levofloxacin |
| Active Ingredient(s): | 25 mg/mL & nbsp; Levofloxacin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17478-107 |
| Labeler Name: | Akorn, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091644 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110701 |
| Package NDC: | 17478-107-30 |
| Package Description: | 1 VIAL in 1 CARTON (17478-107-30) > 30 mL in 1 VIAL |
| NDC Code | 17478-107-30 |
| Proprietary Name | Levofloxacin |
| Package Description | 1 VIAL in 1 CARTON (17478-107-30) > 30 mL in 1 VIAL |
| Product NDC | 17478-107 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levofloxacin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110701 |
| Marketing Category Name | ANDA |
| Labeler Name | Akorn, Inc. |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |